UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 149

Sortiert nach

Hypoxia inducible factor-1 alpha and carbonic anhydrase IX overexpression are associated with poor survival in breast cancer patients

Journal of B.U. ON., 2012-10, Vol.17 (4), p.663-668

2012

Link zum Volltext

Verfügbarkeit prüfen

Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony‐stimulating factor (rhG‐CSF): a randomized evaluation of different doses of rhG‐CSF

British journal of haematology, 2002-02, Vol.116 (2), p.468-474

2002

Link zum Volltext

Verfügbarkeit prüfen

Effect of tamoxifen on serum IL‐18, vascular endothelial growth factor and nitric oxide activities in breast carcinoma patients

Clinical and experimental immunology, 2004-09, Vol.137 (3), p.546-551

2004

Link zum Volltext

Verfügbarkeit prüfen

21 Primary hepatic low-grade B-cell lymphoma: A case report

European journal of cancer supplements, 2010, Vol.8 (4), p.13-14

2010

Link zum Volltext

Verfügbarkeit prüfen

No association between serum levels of insulin-like growth factor-I, vascular endothelial growth factor, prolactin and clinicopathological characteristics of breast carcinoma after surgery

Internal medicine journal, 2004-06, Vol.34 (6), p.310-315

2004

Link zum Volltext

Verfügbarkeit prüfen

Tamoxifen therapy and hepatic steatosis

Neoplasma, 2002, Vol.49 (1), p.61

2002

Link zum Volltext

Verfügbarkeit prüfen

High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation

Bone marrow transplantation (Basingstoke), 2003-05, Vol.31 (9), p.755-761

2003

Link zum Volltext

Verfügbarkeit prüfen

A randomized trial of assessment of efficacy of leukapheresis volumes, 8 liters vs 12 liters

Bone marrow transplantation (Basingstoke), 2002-06, Vol.29 (11), p.893-897

2002

Link zum Volltext

Verfügbarkeit prüfen

2143P Mortality within 30 days after last dose of intravenous systemic anti-cancer therapy: Single-center, one-year, retrospective analysis

Annals of oncology, 2023-10, Vol.34, p.S1116-S1116

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical importance of serum interleukin‐18 and nitric oxide activities in breast carcinoma patients

Cancer, 2002-08, Vol.95 (3), p.663-667

2002

Link zum Volltext

Verfügbarkeit prüfen

PP-109 CHROMATIN MODIFICATION GENES PLAY PIVOTAL ROLE IN BORTEZOMIB INDUCED GROWTH SUPPRESSION IN CHRONIC MYELOID LEUKEMIA

Leukemia research, 2014-10, Vol.38, p.S61-S61

2014

Link zum Volltext

Verfügbarkeit prüfen

PP-108 BORTEZOMIB: A PROMISING TARGET FOR ENDOPLASMIC RETICULUM STRESS-INDUCED APOPTOSIS IN CHRONIC MYELOID LEUKEMIA

Leukemia research, 2014-10, Vol.38, p.S61-S61

2014

Link zum Volltext

Verfügbarkeit prüfen

PP-117 EVALUATING EXPRESSION PATTERNS OF STAT5A AND STAT5B REGULATED MIRNASIN BORTEZOMIB TREATED CML CELL MODEL WITH INCREASED APOPTOSIS LEVELS

Leukemia research, 2014-10, Vol.38, p.S64-S64

2014

Link zum Volltext

Verfügbarkeit prüfen

510P Long-term outcomes of COVID-19 infection in patients with solid tumors before vaccination

Annals of oncology, 2022-09, Vol.33, p.S776-S776

2022

Link zum Volltext

Verfügbarkeit prüfen

Cisplatin plus vinorelbine as a salvage regimen in refractory breast cancer

Tumori, 2000-07, Vol.86 (4), p.283-285

2000

Link zum Volltext

Verfügbarkeit prüfen

1603P The ability of the LACE index to predict 30-day readmissions in oncology patients

Annals of oncology, 2023-10, Vol.34, p.S889-S889

2023

Link zum Volltext

Verfügbarkeit prüfen

Inhibitory Effect of 5‐Fluorouracil on Cytochrome P450 2C9 Activity in Cancer Patients

Basic & clinical pharmacology & toxicology, 2006-02, Vol.98 (2), p.197-200

2006

Link zum Volltext

Verfügbarkeit prüfen

Effect of cisplatin on skin metastasis in breast cancer patients

Onkologie, 2001-12, Vol.24 (6), p.576

2001

Link zum Volltext

Verfügbarkeit prüfen

Effect of different neoadjuvant chemotherapy regimens on locally advanced breast cancer

Neoplasma, 2003, Vol.50 (3), p.210

2003

Link zum Volltext

Verfügbarkeit prüfen

Association of hypoxia inducible factor-1 alpha and carbonic anhydrase IX overexpression and survival in HER2/neu positive hormone-unresponsive breast cancer patients

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e22078-e22078

2009

Link zum Volltext

Verfügbarkeit prüfen

Serum leptin, prolactin and vascular endothelial growth factor (VEGF) levels in patients with breast cancer

Neoplasma, 2003, Vol.50 (1), p.41

2003

Link zum Volltext

Verfügbarkeit prüfen

976P The 30-day mortality rate after first cycle of immunotherapy

Annals of oncology, 2021-09, Vol.32, p.S837-S837

2021

Link zum Volltext

Verfügbarkeit prüfen

Serum hepatocyte growth factor and interleukin-6 levels can distinguish patients with primary or metastatic liver tumors from those with benign liver lesions

Neoplasma, 2004, Vol.51 (3), p.209

2004

Link zum Volltext

Verfügbarkeit prüfen

Significance of serum vascular endothelial growth factor, insulin-like growth factor-I levels and nitric oxide activity in breast cancer patients

Breast (Edinburgh), 2003-04, Vol.12 (2), p.104-110

2003

Link zum Volltext

Verfügbarkeit prüfen

Effect of tamoxifen on serum IL-18, vasular endothelial growth factor and nitric oxide activities in breast carcinoma patients

Clinical and experimental immunology, 2004-09, Vol.137 (3), p.546

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 149

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(142)
Mit Volltextzugriff
(128)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Hypoxia inducible factor-1 alpha and carbonic anhydrase IX overexpression are associated with poor survival in breast cancer patients

Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony‐stimulating factor (rhG‐CSF): a randomized evaluation of different doses of rhG‐CSF

Effect of tamoxifen on serum IL‐18, vascular endothelial growth factor and nitric oxide activities in breast carcinoma patients

21 Primary hepatic low-grade B-cell lymphoma: A case report

No association between serum levels of insulin-like growth factor-I, vascular endothelial growth factor, prolactin and clinicopathological characteristics of breast carcinoma after surgery

Tamoxifen therapy and hepatic steatosis

High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation

A randomized trial of assessment of efficacy of leukapheresis volumes, 8 liters vs 12 liters

2143P Mortality within 30 days after last dose of intravenous systemic anti-cancer therapy: Single-center, one-year, retrospective analysis

Clinical importance of serum interleukin‐18 and nitric oxide activities in breast carcinoma patients

PP-109 CHROMATIN MODIFICATION GENES PLAY PIVOTAL ROLE IN BORTEZOMIB INDUCED GROWTH SUPPRESSION IN CHRONIC MYELOID LEUKEMIA

PP-108 BORTEZOMIB: A PROMISING TARGET FOR ENDOPLASMIC RETICULUM STRESS-INDUCED APOPTOSIS IN CHRONIC MYELOID LEUKEMIA

PP-117 EVALUATING EXPRESSION PATTERNS OF STAT5A AND STAT5B REGULATED MIRNASIN BORTEZOMIB TREATED CML CELL MODEL WITH INCREASED APOPTOSIS LEVELS

510P Long-term outcomes of COVID-19 infection in patients with solid tumors before vaccination

Cisplatin plus vinorelbine as a salvage regimen in refractory breast cancer

1603P The ability of the LACE index to predict 30-day readmissions in oncology patients

Inhibitory Effect of 5‐Fluorouracil on Cytochrome P450 2C9 Activity in Cancer Patients

Effect of cisplatin on skin metastasis in breast cancer patients

Effect of different neoadjuvant chemotherapy regimens on locally advanced breast cancer

Association of hypoxia inducible factor-1 alpha and carbonic anhydrase IX overexpression and survival in HER2/neu positive hormone-unresponsive breast cancer patients

Serum leptin, prolactin and vascular endothelial growth factor (VEGF) levels in patients with breast cancer

976P The 30-day mortality rate after first cycle of immunotherapy

Serum hepatocyte growth factor and interleukin-6 levels can distinguish patients with primary or metastatic liver tumors from those with benign liver lesions

Significance of serum vascular endothelial growth factor, insulin-like growth factor-I levels and nitric oxide activity in breast cancer patients

Effect of tamoxifen on serum IL-18, vasular endothelial growth factor and nitric oxide activities in breast carcinoma patients

Suchergebnisse filtern